- Home
- PNW vs RVMD Comparison
PNW vs RVMD Comparison
Compare PNW & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PNW | RVMD |
|---|---|---|
| Founded | 1985 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1B | 15.2B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | PNW | RVMD |
|---|---|---|
| Price | $92.97 | $98.81 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 16 |
| Target Price | $95.18 | ★ $100.13 |
| AVG Volume (30 Days) | 1.3M | ★ 5.6M |
| Earning Date | 02-25-2026 | 02-25-2026 |
| Dividend Yield | ★ 3.89% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.92 | N/A |
| Revenue | ★ $5,307,180,000.00 | N/A |
| Revenue This Year | $5.02 | N/A |
| Revenue Next Year | $3.96 | $740.40 |
| P/E Ratio | $19.05 | ★ N/A |
| Revenue Growth | ★ 5.70 | N/A |
| 52 Week Low | $85.03 | $29.17 |
| 52 Week High | $96.50 | $124.49 |
Technical Indicators
Market Signals| Indicator | PNW | RVMD |
|---|---|---|
| Relative Strength Index (RSI) | 57.95 | 48.51 |
| Support Level | $91.73 | $96.72 |
| Resistance Level | $95.00 | $101.93 |
| Average True Range (ATR) | 1.70 | 4.80 |
| MACD | 0.17 | -3.18 |
| Stochastic Oscillator | 67.49 | 19.72 |
Price Performance
Historical ComparisonAbout PNW Pinnacle West Capital Corporation
Pinnacle West is a holding company whose principal subsidiary is Arizona Public Service, a vertically integrated electric utility serving approximately 1.4 million customers across a 35,000-square-mile territory in central Arizona, including the Phoenix area. APS owns or leases 6.5 gigawatts of power generation capacity, including a 29% ownership stake in one of the largest nuclear plants in the US, Palo Verde. Half of the electricity that APS supplies to customers comes from clean energy sources, including nuclear.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.